Vasodilators and Ventricular Septal Defect: Comparison of Prazosin, Minoxidil, and Hydralazine in a Chronic Lamb Model
- 1 September 1984
- journal article
- research article
- Published by Springer Nature in Pediatric Research
- Vol. 18 (9) , 859-864
- https://doi.org/10.1203/00006450-198409000-00011
Abstract
Pediatric Research publishes original papers, invited reviews, and commentaries on the etiologies of diseases of children and disorders of development, extending from molecular biology to epidemiology. Use of model organisms and in vitro techniques relevant to developmental biology and medicine are acceptable, as are translational human studies.Keywords
This publication has 9 references indexed in Scilit:
- Significance of systemic vascular resistance in determining the hemodynamic effects of hydralazine on large ventricular septal defects.Circulation, 1983
- Hemodynamic effects of hydralazine in infants with a large ventricular septal defect.Circulation, 1982
- α2- and α2-vasular adrenoceptors in the dogEuropean Journal of Pharmacology, 1980
- Vasodilator therapy for congestive heart failureThe Journal of Pediatrics, 1980
- Oral Hydralazine Therapy for Primary Pulmonary HypertensionNew England Journal of Medicine, 1980
- Sustained Reduction of Cardiac Impedance and Preload in Congestive Heart Failure with the Antihypertensive Vasodilator PrazosinNew England Journal of Medicine, 1977
- Hemodynamic effects of vasodilator agents in dogs with experimental ventricular septal defects.Circulation, 1976
- HEMODYNAMIC EFFECTS OF PRAZOSIN1976
- Physical factors affecting normal and serotonin-constricted pulmonary vesselsAmerican Journal of Physiology-Legacy Content, 1960